against n1 icd Search Results


97
Cell Signaling Technology Inc against n1 icd
Against N1 Icd, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/against n1 icd/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
against n1 icd - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

86
Danaher Inc rabbit polyclonal antibody against notch1 intracellular domain
Rabbit Polyclonal Antibody Against Notch1 Intracellular Domain, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal antibody against notch1 intracellular domain/product/Danaher Inc
Average 86 stars, based on 1 article reviews
rabbit polyclonal antibody against notch1 intracellular domain - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology notch1 antibodies
Representative Western blot results are shown. SIL treatment decreased <t>Notch1,</t> RBP-Jκ, Hes1, Bcl2, cyclin D1, and survivin expression, and increased Bax expression. The results are expressed as the means ± SEM, n = 6. aa P<0.01, compared with the control group, bb P<0.01, compared with the 50 µM SIL-treated group, and cc P<0.01, compared with the 100 µM SIL-treated group. SIL, silybin.
Notch1 Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/notch1 antibodies/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
notch1 antibodies - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cell Signaling Technology Inc cleaved notch1 intracellular domain (cnicd) antibody
Representative Western blot results are shown. SIL treatment decreased <t>Notch1,</t> RBP-Jκ, Hes1, Bcl2, cyclin D1, and survivin expression, and increased Bax expression. The results are expressed as the means ± SEM, n = 6. aa P<0.01, compared with the control group, bb P<0.01, compared with the 50 µM SIL-treated group, and cc P<0.01, compared with the 100 µM SIL-treated group. SIL, silybin.
Cleaved Notch1 Intracellular Domain (Cnicd) Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cleaved notch1 intracellular domain (cnicd) antibody/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
cleaved notch1 intracellular domain (cnicd) antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc antibody against notch1 intracellular domain
Representative Western blot results are shown. SIL treatment decreased <t>Notch1,</t> RBP-Jκ, Hes1, Bcl2, cyclin D1, and survivin expression, and increased Bax expression. The results are expressed as the means ± SEM, n = 6. aa P<0.01, compared with the control group, bb P<0.01, compared with the 50 µM SIL-treated group, and cc P<0.01, compared with the 100 µM SIL-treated group. SIL, silybin.
Antibody Against Notch1 Intracellular Domain, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody against notch1 intracellular domain/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
antibody against notch1 intracellular domain - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

Image Search Results


Representative Western blot results are shown. SIL treatment decreased Notch1, RBP-Jκ, Hes1, Bcl2, cyclin D1, and survivin expression, and increased Bax expression. The results are expressed as the means ± SEM, n = 6. aa P<0.01, compared with the control group, bb P<0.01, compared with the 50 µM SIL-treated group, and cc P<0.01, compared with the 100 µM SIL-treated group. SIL, silybin.

Journal: PLoS ONE

Article Title: Silybin-Mediated Inhibition of Notch Signaling Exerts Antitumor Activity in Human Hepatocellular Carcinoma Cells

doi: 10.1371/journal.pone.0083699

Figure Lengend Snippet: Representative Western blot results are shown. SIL treatment decreased Notch1, RBP-Jκ, Hes1, Bcl2, cyclin D1, and survivin expression, and increased Bax expression. The results are expressed as the means ± SEM, n = 6. aa P<0.01, compared with the control group, bb P<0.01, compared with the 50 µM SIL-treated group, and cc P<0.01, compared with the 100 µM SIL-treated group. SIL, silybin.

Article Snippet: SIL, DAPT (a known Notch1 inhibitor), Notch1 siRNA and antibodies that had been raised against the Notch1 intracellular domain (NICD), Hes1, and RBP-Jκ were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA).

Techniques: Western Blot, Expressing, Control

A. Viability is expressed as OD values. B. Representative Western blot results are shown. The results are expressed as the means ± SEM, n = 6. aa P<0.01, compared with the control group, bb P<0.01, compared with the 100 µM SIL-treated group, and cc P<0.01, compared with the Notch1 siRNA-transfected +100 µM SIL-treated group. SIL, silybin. OD, optical density.

Journal: PLoS ONE

Article Title: Silybin-Mediated Inhibition of Notch Signaling Exerts Antitumor Activity in Human Hepatocellular Carcinoma Cells

doi: 10.1371/journal.pone.0083699

Figure Lengend Snippet: A. Viability is expressed as OD values. B. Representative Western blot results are shown. The results are expressed as the means ± SEM, n = 6. aa P<0.01, compared with the control group, bb P<0.01, compared with the 100 µM SIL-treated group, and cc P<0.01, compared with the Notch1 siRNA-transfected +100 µM SIL-treated group. SIL, silybin. OD, optical density.

Article Snippet: SIL, DAPT (a known Notch1 inhibitor), Notch1 siRNA and antibodies that had been raised against the Notch1 intracellular domain (NICD), Hes1, and RBP-Jκ were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA).

Techniques: Western Blot, Control, Transfection